-
Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Projects (Collaborative U01 - Clinical Trial Not Allowed)
(RFA-AA-20-003)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): December 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted in response to this FOA
-
Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trial Not Allowed)
(RFA-AA-20-004)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): December 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted in response to this FOA
-
Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trial Not Allowed)
(RFA-AA-20-005)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): December 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted in response to this FOA
-
Low Cost Detection of Cognitive Decline in Clinical Settings (R61/R33 Clinical Trial Required)
(RFA-AG-20-050)
National Institute on Aging
Application Receipt Date(s): January 30, 2020
No late applications will be accepted for this funding opportunity announcement.
-
Low Cost Detection of Cognitive Decline in Clinical Settings (R01 Clinical Trial Required)
(RFA-AG-20-051)
National Institute on Aging
Application Receipt Date(s): January 30,2020 No late applications will be accepted for this funding opportunity announcement.
-
Limited Competition: Pediatric Brain Tumor Consortium (UM1 Clinical Trials Required)
(RFA-CA-19-059)
National Cancer Institute
Application Receipt Date(s): November 13, 2019
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)
(RFA-DA-20-027)
National Institute on Drug Abuse
Application Receipt Date(s): January 15, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Continuation of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CPDPC-CCs) (U01 Clinical Trial Optional)
(RFA-DK-19-009)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Application Receipt Date(s): December 17, 2019, by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement
-
Understanding the Functional Contributions and Mechanisms of Type 2 Diabetes Disease-associated Variants (UM1 Clinical Trial Not Allowed)
(RFA-DK-19-012)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): December 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition: Continuation of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Management Center (CPDPC-CDMC) (U01 Clinical Trial Optional)
(RFA-DK-19-504)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Application Receipt Date(s): December 17, 2019
No Late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition for the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes Knowledge Portal (UM1 Clinical Trial Not Allowed)
(RFA-DK-19-505)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): December 3, 2019
No late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition: Specialized Centers of Excellence on Environmental Health Disparities Research (P50)
(RFA-MD-20-001)
National Institute on Minority Health and Health Disparities
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): November 22, 2019
All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Tobacco Regulatory Science (R01 Clinical Trial Optional)
(RFA-OD-19-028)
Office of Disease Prevention
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Heart, Lung, and Blood Institute
Application Receipt Date(s): February 13, 2020, July 17, 2020, February 13, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
(RFA-OD-19-029)
Office of Research on Women's Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Nursing Research
National Center for Complementary and Integrative Health
Application Receipt Date(s): November 25, 2019; November 25, 2020, November 26, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
No late applications will be accepted for this Funding Opportunity Announcement
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.